バイオエレクトロニクスを利用した神経調節療法を使用して,インスリン抵抗性とその併発症と闘う
Yosra Magdi Mekki1, Jeongeun Park1, Zeinah Alzaareer1
1Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Journal of diabetes and metabolic disorders
|February 16, 2026
まとめ
神経調節,特に迷走神経刺激は,神経内分泌系を標的とし,炎症を軽減することにより,インスリン抵抗性の管理に有望であることが示されています. 代謝障害に対するこれらの新しい治療法を最適化するために,さらなる研究が必要である.
科学分野:
- メタボリック障害 メタボリック障害
- 神経内分泌学の神経内分泌学
- 神経調節は神経調節によるものです.
背景:
- インスリン抵抗性は,インスリンシグナル伝達を妨害し,全身的な合併症につながる複雑な代謝障害です.
- それは複数の複雑な分子経路を伴う.
- その神経内分泌の基盤を理解することは極めて重要です.
研究 の 目的:
- インスリン抵抗性の管理のための神経調節に関する文献をレビューする.
- 代謝性ホメオスタシスにおける神経代謝反射の役割を調査する.
- 神経調節療法における課題と将来の方向性を特定する.
主な方法:
- 関連する出版論文の包括的な文献検索.
- 研究の選択のためにPubMedのようなデータベースを利用した.
- 選択された文献から集約された発見.
主要な成果:
- 神経調節は,神経内分泌システムを標的にし,神経回路調節を統合することによって,インスリン抵抗性を管理することができます.
- ヴァガス神経の刺激は,特に炎症を軽減し,インスリン抵抗性および併発症と闘います.
- 治療効果を最大化し,有害事象を最小限に抑え,高度なシステムで倫理的検討に取り組むという課題は依然として残っています.
結論:
- 神経調節は,インスリン抵抗性などの代謝障害に対する新しい治療法を提供します.
- 神経代謝反射の理解を深めることは,より安全で効果的な神経調節治療の開発に不可欠です.
関連する概念動画
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Insulin: The Receptor and Signaling Pathways
3.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Insulin: Dosing Regimen and Adverse Effects
857
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
857
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Hormones Regulating Blood Glucose
7.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.1K


